Meningioma Overview

Save information for later
Sign Up

Learn About Meningioma

View Main Condition: Brain Tumor

What is the definition of Meningioma?
Meningiomas are tumors that originate in the meninges, the membranes that surround the brain and spinal cord. Most Meningiomas are not cancerous (benign), though a minority of Meningiomas can be classified as atypical or cancerous (malignant). Though rare, malignant Meningiomas can be highly aggressive. However, even benign Meningiomas can cause problems if their growth affects neighboring areas of the brain. Though most Meningiomas grow slowly, there is no way to predict the rate of growth for a particular Meningioma or to know how long a specific Meningioma was growing before it was diagnosed. Signs and symptoms can vary but may include seizures, headaches, weakness in the arms and legs, and vision loss. Sometimes memory loss, carelessness, and unsteadiness are the only symptoms.
What are the alternative names for Meningioma?
  • Meningioma
Who are the top Meningioma Local Doctors?
Allan H. Friedman
Elite in Meningioma
Dr. Allan H. Friedman
Neurosurgery
Elite in Meningioma
Dr. Allan H. Friedman
Neurosurgery

Duke Cancer Center Brain Tumor Clinic

20 Duke Medicine Cir, 
Durham, NC 
919-684-5301
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients
Offers Telehealth

Allan Friedman is a Neurosurgery provider in Durham, North Carolina. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Meningioma. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, Awake Craniotomy, and Laminectomy. Dr. Friedman is currently accepting new patients.

Elite in Meningioma
Dr. Douglas S. Kondziolka
Neurosurgery
Elite in Meningioma
Dr. Douglas S. Kondziolka
Neurosurgery

New York University

111 Broadway, Fl 2, 
New York, NY 
212-263-9701
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Douglas Kondziolka is a Neurosurgery provider in New York, New York. Dr. Kondziolka is rated as an Elite provider by MediFind in the treatment of Meningioma. His top areas of expertise are Schwannoma, Acoustic Neuroma, Arteriovenous Malformation, Gamma Knife Radiosurgery, and Endovascular Embolization.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Meningioma
Dr. Vikram C. Prabhu
Neurosurgery
Elite in Meningioma
Dr. Vikram C. Prabhu
Neurosurgery

Loyola University Medical Center

2160 S 1st Ave, 
Maywood, IL 
708-216-9000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Vikram Prabhu is a Neurosurgery provider in Maywood, Illinois. Dr. Prabhu is rated as an Elite provider by MediFind in the treatment of Meningioma. His top areas of expertise are Meningioma, Familial Porencephaly, Hydrocephalus, Awake Craniotomy, and Osteotomy. Dr. Prabhu is currently accepting new patients.

View All Doctors
What are the latest Meningioma Clinical Trials?
A First-in-human Phase I Single-agent Dose-escalation, Food Effect and Dose Expansion Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
A First-in-human Phase I Single-agent Dose-escalation, Food Effect and Dose Expansion Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Who is this study for: Patients with recurrent and rare primary central nervous system neoplasms
Enrollment Status: Recruiting
Publish Date: December 17, 2025
Intervention Type: Drug
Study Drug: ONC206
Study Phase: Phase 1

Summary: The primary objective of this Phase 1, open-label, dose-escalation, and exploratory study is to evaluate the safety and tolerability profile (establish the maximum-tolerated dose) and evaluate the occurrence of dose-limiting toxicities (DLTs) following single weekly or multiple-day weekly dose regimens of single-agent, oral ONC206 in patients with recurrent, primary central nervous system (CNS) ne...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients
Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients
Enrollment Status: Recruiting
Publish Date: December 15, 2025

Summary: Meningiomas are the most common primary intracranial tumors. Current treatment relies on surgical resection and radiotherapy, but molecular predictors for recurrence are lacking. This study aims to investigate epigenetic features, specifically histone post-translational modifications (PTMs) and DNA methylation, to stratify patients. The study involves a retrospective cohort to define an epigenetic...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 11, 2022
Published By: Genetic and Rare Diseases Informnation Center